What is the Impact Factor of Cardiovascular Diabetology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cardiovascular Diabetology is 15.6, ranking in quartile Q1 of Web of Science (SCIE).

Is Cardiovascular Diabetology indexed in Web of Science or Scopus?

Yes, Cardiovascular Diabetology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 4.447 (Q1) and an H-index of 135.

Who publishes Cardiovascular Diabetology and what is the Article Processing Charge (APC)?

Cardiovascular Diabetology is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $4,088 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cardiovascular Diabetology?

The official ISO-4 abbreviation of Cardiovascular Diabetology is "CARDIOVASC DIABETOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #360Top JournalGold OA

Cardiovascular Diabetology

Abbreviation (ISO):CARDIOVASC DIABETOL

•

Identifier (ISSN):1475-2840(Print)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

15.6↑ +5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cardiovascular Diabetology

WoS Q1

Annual Impact Factor Metric

Current (2026):15.6

Scopus SJR & RankScopus Q1

4.447

#360

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

135

135 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate16.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

217articles/year

100% Gold OA•90.85% Original Research

Aims & Scope

Cardiovascular Diabetology is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome; this includes genetic, experimental, clinical, pharmacological, epidemiological, molecular biology and laboratory research. Cardiovascular Diabetology aims to provide an address for all types of scientific communications related to the diabetes/cardiovascular interrelationship and the dysmetabolic syndrome. The impressive correlation between coronary artery disease and alterations in glucose metabolism has raised the likelihood that atherosclerosis and type 2 diabetes may share common antecedents.

Topics Covered (Recognized by AI)

Medicine99.8%Internal medicine99.7%Biology98.6%Endocrinology97.3%Diabetes mellitus90.4%Cardiology71.8%Pathology71.2%Psychology58.6%Psychiatry57.3%Type 2 diabetes48.1%Chemistry47.8%Biochemistry46.2%Angiology40.3%Mathematics37.9%Surgery36.3%Statistics36.1%Biotechnology34.3%Insulin33.6%Obesity30.8%Genetics30.2%Radiology28.1%Myocardial infarction20.4%Blood pressure20.3%Type 2 Diabetes Mellitus20.3%

Primary Research Areas

Medicine Endocrinology & Metabolism

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Rank7/237

IndexSCIE

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank10/198

IndexSCIE

JCISCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Rank8/237

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank7/198

IndexSCIE

Category	Index	Rank	Quartile
CARDIAC & CARDIOVASCULAR SYSTEMS	JCRSCIE	7/237	Q1
ENDOCRINOLOGY & METABOLISM	JCRSCIE	10/198	Q1
CARDIAC & CARDIOVASCULAR SYSTEMS	JCISCIE	8/237	Q1
ENDOCRINOLOGY & METABOLISM	JCISCIE	7/198	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF15.6

Articles / Year332

Total Citations555

2025

IF10.6

Articles / Year495

Total Citations7,967

2024

IF8.5

Articles / Year456

Total Citations13,821

2023

IF9.3

Articles / Year353

Total Citations15,630

2022

IF8.949

Articles / Year294

Total Citations16,454

Year	Impact Factor	Articles / Year	Total Citations
2026	15.6	332	555
2025	10.6	495	7,967
2024	8.5	456	13,821
2023	9.3	353	15,630
2022	8.949	294	16,454
2021	9.951	244	14,054
2020	7.332	214	14,050
2019	5.948	173	12,629
2018	5.235	162	17,177
2017	—	160	10,611
2016	—	167	8,961
2015	—	154	7,382

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #360Scopus Q1SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q1

4.447

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

14.57

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,088 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations15,259

3-Year Documents1,066

Citable Documents1,051

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ1

Endocrinology, Diabetes and MetabolismQ1

Internal MedicineQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 16.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

2区CARDIAC & CARDIOVASCULAR SYSTEMS

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cardiovascular Diabetology (abbr: CARDIOVASC DIABETOL, ISSN: 1475-2840) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 15.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 4.447 (Q1), an H-index of 135.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 217 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,088 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.